On 2026-03-02, Belite Bio, Inc. Sponsored ADR (BLTE) announced earnings per share of $-0.38 for the fiscal quarter ending 2025-12-31, beating the average analyst estimate of $-0.56.
The next expected annoucement date for quarterly earnings is 2026-05-12, with an average estimated earnings per share of $-0.60 for the fiscal quarter ending 2026-03-31.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2026-03-02 | 2025-12-31 | $-0.56 | $-0.38 |
| 2025-11-10 | 2025-09-30 | $-0.53 | $-0.65 |
| 2025-08-11 | 2025-06-30 | $-0.47 | $-0.50 |
| 2025-05-13 | 2025-03-31 | $-0.36 | $-0.45 |
| 2025-03-17 | 2024-12-31 | $-0.30 | $-0.32 |
| 2024-11-12 | 2024-09-30 | $-0.30 | $-0.28 |
| 2024-08-09 | 2024-06-30 | $-0.28 | $-0.31 |
| 2024-05-13 | 2024-03-31 | $-0.34 | $-0.27 |
| 2024-03-11 | 2023-12-31 | $-0.36 | $-0.25 |
| 2023-11-13 | 2023-09-30 | $-0.31 | $-0.40 |
| 2023-08-08 | 2023-06-30 | $-0.24 | $-0.26 |
| 2023-05-10 | 2023-03-31 | $-0.17 | $-0.33 |